000			01331 a2200397 4500
005			20250511195819.0
264		0	_c19911218
008			199112s 0 0 eng d
022			_a0300-9572
024	7		_a10.1016/0300-9572(91)90066-8 _2doi
040			_aNLM _beng _cNLM
100	1		_aGriffin, M P
245	0	0	_aIbuprofen therapy in experimental porcine gram-negative septic shock. _h[electronic resource]
260			_bResuscitation _cAug 1991
300			_a75-83 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_a6-Ketoprostaglandin F1 alpha _xblood
650	0	4	_aAnimals
650	0	4	_aEscherichia coli Infections _xblood
650	0	4	_aIbuprofen _xtherapeutic use
650	0	4	_aLeukocyte Count
650	0	4	_aPeritonitis _xdrug therapy
650	0	4	_aPlatelet Count
650	0	4	_aPulmonary Circulation _xdrug effects
650	0	4	_aShock, Septic _xblood
650	0	4	_aSwine
650	0	4	_aThromboxane B2 _xblood
650	0	4	_aVascular Resistance _xdrug effects
700	1		_aGore, D C
700	1		_aLobe, T E
700	1		_aFlynn, J F
700	1		_aTraber, D L
700	1		_aHerndon, D N
773	0		_tResuscitation _gvol. 22 _gno. 1 _gp. 75-83
856	4	0	_uhttps://doi.org/10.1016/0300-9572(91)90066-8 _zAvailable from publisher's website
999			_c1665373 _d1665373